8 results match your criteria: "National Cancer Institute University of Gezira[Affiliation]"
J Comput Biol
May 2024
Department of Molecular Biology, National Cancer Institute-University of Gezira, Wad Madani, Sudan.
.
View Article and Find Full Text PDFGlob Epidemiol
December 2022
Department of Oncology, National Cancer Institute - University of Gezira (NCI-UG), Wad Medani, Sudan.
Background: Breast cancer (BC) is the most frequently diagnosed cancer and a major cause of cancer mortality in Sudan. However, there is lack of data related to BC relapse. Therefore, this study was undertaken to estimate the 5-year relapse free survival (RFS) rate and factors related to BC relapse in Sudanese women with non-metastatic BC.
View Article and Find Full Text PDFThyroid Res
August 2023
Department of Molecular Biology, National Cancer Institute - University of Gezira, Wad Medani, Sudan.
Background: In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer. To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gezira (NCI-UG), Sudan.
Methods: We performed a retrospective health facility-based study of patients with thyroid cancer who were treated at NCI-UG from January 2009 to December 2017.
Pharmaceutics
November 2022
EA6295 Nanomédicaments et Nanosondes, Université de Tours, 37200 Tours, France.
According to Globocan 2020, breast cancer is considered one of the most common cancers affecting women and is one of the leading causes of death in over 100 countries. The available classical treatment options do not always give satisfactory outcomes, and some patients develop resistance to these treatments. This study aims to investigate the combination of nanovectorized siRNA directed against anti-apoptotic protein Survivin (siSurvivin) by targeted stealth magnetic siRNA nanovectors (TS-MSN), designed in our lab, with Doxorubicin (DOX), as an option for HER2+ breast cancer treatment.
View Article and Find Full Text PDFJCO Glob Oncol
February 2021
Department of Molecular Biology, National Cancer Institute-University of Gezira (NCI-UG), Wad Medani, Sudan.
Purpose: Breast cancer (BC) is the leading malignancy among Sudanese women. Yet, data on survival are limited. This study aimed to determine 5-year overall survival (OS) of BC in Sudanese women, and identify prognostic demographic and clinicopathologic factors.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
September 2015
Department of Biochemistry and Nutrition, Faculty of Medicine, University of Gezira ; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Background: Type 2 diabetes is emerging in Sudan and is associated with obesity. Deregulated lipid metabolism and inflammatory states are suggested risk factors for cardiovascular disease, which is a leading cause of diabetic death. This study aimed to investigate C-reactive protein (CRP) levels and the lipid profile in type 2 diabetic adult Sudanese compared with nondiabetics, and to test their associations with other characteristics.
View Article and Find Full Text PDFOphthalmic Genet
June 2011
Department of Oncology, National Cancer Institute-University of Gezira, Wad- Sudan.
Background: Retinoblastoma (RB) is a rare and unique cancer that affects the eyes of very young children. There are few reports on RB in Sudan.
Materials And Methods: We performed a retrospective study of data from patients diagnosed with retinoblastoma between January 1999 and December 2009 at the National Cancer Institute in Gezira (NCI-Gezira).
Sci Total Environ
April 2012
Department of Molecular Biology, National Cancer Institute University of Gezira, Wadmedani, Sudan.
Quality-assessed biomedical samples are essential for academia- and industry driven research on human diseases. The etiologies and the molecular genetic factors relevant in African diseases, including both infections and complex degenerative diseases as well as cancer, need to be studied using well annotated and well-preserved biosamples acquired from native African ethnic groups and compare the results with non-African populations and/or with Afro-Americans. However, a number of difficulties negatively impact on the possibility to obtain clinically annotated biological samples in most Sub-Saharan African countries.
View Article and Find Full Text PDF